GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Maccura Biotechnology Co Ltd (SZSE:300463) » Definitions » 3-Year EPS without NRI Growth Rate

Maccura Biotechnology Co (SZSE:300463) 3-Year EPS without NRI Growth Rate : -49.00% (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Maccura Biotechnology Co 3-Year EPS without NRI Growth Rate?

Maccura Biotechnology Co's EPS without NRI for the three months ended in Mar. 2025 was ¥0.06.

During the past 12 months, Maccura Biotechnology Co's average EPS without NRI Growth Rate was -69.80% per year. During the past 3 years, the average EPS without NRI Growth Rate was -49.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was -25.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was 0.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Maccura Biotechnology Co was 29.30% per year. The lowest was -49.00% per year. And the median was 9.90% per year.


Competitive Comparison of Maccura Biotechnology Co's 3-Year EPS without NRI Growth Rate

For the Diagnostics & Research subindustry, Maccura Biotechnology Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Maccura Biotechnology Co's 3-Year EPS without NRI Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Maccura Biotechnology Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Maccura Biotechnology Co's 3-Year EPS without NRI Growth Rate falls into.


;
;

Maccura Biotechnology Co 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Maccura Biotechnology Co  (SZSE:300463) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Maccura Biotechnology Co 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Maccura Biotechnology Co's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Maccura Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
Number 8, 2nd Anhe Road, Hi-tech Zone, Chengdu, CHN, 611731
Maccura Biotechnology Co Ltd is a China-based in-vitro diagnostic (IVD) integration company engaged in the research and development, production and sales of IVD products. It is also engaged in the sales of foreign brands of in vitro diagnostic products as an agent. The company's developed product and technology development platforms cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.
Executives
Guo Lei Director
Wang Deng Ming Directors, executives
Wang Lin Supervisors
Wu Ming Jian Directors, executives
Shi Wei Directors, executives
Yang Hui Supervisors
Zhou Yue Guo Executives
Wang Zhen Executives
Yu Ping Executives
Zou Yuan Supervisors
Xu Sheng Guo Directors, executives
Liu Qi Lin Directors, executives
Chu Jian Jun Executives
Tang Yong Director
Xu Jin Song Executives

Maccura Biotechnology Co Headlines

No Headlines